Synthesis and biological evaluation of new sulfonamide derivatives as potential anti-Trypanosoma cruzi agents

Research output: Contribution to journalArticlepeer-review

12 Scopus citations

Abstract

Chagas disease continues to be one of the main parasitic diseases in Latin America. Despite the fact that it was discovered more than 100 years ago, no suitable pharmacologic treatment is available. We report the synthesis of new sulfonamidoquinoline and sulfonamides derivatives that were evaluated in vitro against two strains of Trypanosoma cruzi (NINOA and INC-5). Structure-activity relationship analysis indicated that small aromatic and large aromatic substituents on 4-aminoquinaldine increased trypanocidal activity on INC-5 and NINOA strains, respectively. Additionally, results show the importance of the sulfonamide group as a scaffold for the development of new anti-T. cruzi agents. Seven sulfonamide derivatives showed better lytic activity than nifurtimox and beznidazole against both strains of T. cruzi. N- (biphenyl-4-yl-sulfonyl)- nicotinamide (P-012) was established as the leader of the series for the development of more effective agents.

Original languageEnglish
Pages (from-to)1039-1044
Number of pages6
JournalMedicinal Chemistry
Volume8
Issue number6
DOIs
StatePublished - Nov 2012

Keywords

  • Biological Activity
  • Chagas
  • Sulfonamide
  • Sulfonamidoquinoline
  • Synthesis
  • Trypanosoma Cruzi

Fingerprint

Dive into the research topics of 'Synthesis and biological evaluation of new sulfonamide derivatives as potential anti-Trypanosoma cruzi agents'. Together they form a unique fingerprint.

Cite this